本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

232.81
-0.6900-0.30%
成交量:84.03萬
成交額:1.97億
市值:143.63億
市盈率:-52.70
高:240.43
開:233.43
低:227.96
收:233.50
52周最高:242.00
52周最低:124.06
股本:6,169.52萬
流通股本:6,008.34萬
量比:1.48
換手率:1.40%
股息:- -
股息率:- -
每股收益(TTM):-4.4176
每股收益(LYR):-4.4176
淨資產收益率:-818.43%
總資產收益率:-6.86%
市淨率:-75.38
市盈率(LYR):-52.70

資料載入中...

2026/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/11

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities